Skip to main content
Top
Published in: European Journal of Drug Metabolism and Pharmacokinetics 6/2016

01-12-2016 | Original Research Article

Stereoselective Pharmacokinetics of Ketoprofen After Oral Administration of Modified-Release Formulations in Caucasian Healthy Subjects

Authors: Marianela Lorier, Laura Magallanes, Manuel Ibarra, Natalia Guevara, Marta Vázquez, Pietro Fagiolino

Published in: European Journal of Drug Metabolism and Pharmacokinetics | Issue 6/2016

Login to get access

Abstract

Background and Objectives

Ketoprofen, a potent nonsteroidal anti-inflammatory drug, is clinically administered as a racemic mixture. One of the possible metabolism routes of ketoprofen is the inversion of the R- to S-enantiomer in the gastrointestinal tract. Ketoprofen, as a weak acid drug, might undergo recirculation through pancreatic/intestinal juices. The aim of the work was to investigate if a plasma-gastrointestinal tract recirculation of ketoprofen could explain its R-to-S chiral inversion after the oral administration of two modified-release formulations: a gastro-resistant delayed-release tablet (Reference) and an extended-release-plus-immediate-release bilayer tablet (Test).

Methods

Sixteen healthy Caucasian volunteers (eight women and eight men) participated in a ketoprofen bioequivalence study. Both formulations were administered with and without food. In both cases, standard meals were given throughout the experiment. R- and S-enantiomers were measured separately using a validated HPLC–UV chiral method. Mean concentration–time profiles of ketoprofen enantiomers in plasma were obtained for men and women. Area under the plasma concentration–time curve, maximum ketoprofen plasma concentration, and time-to-peak were also computed for both isomers, both modes of administration, and both sexes. S/R concentration ratio was assessed as an indicator of enantiomer chiral inversion rate.

Results

Differences in the pharmacokinetics of S- and R-ketoprofen enantiomers were found after the Test administration. S-Ketoprofen presented a lower plasma exposure compared to R-enantiomer. However, the S/R concentration ratio increased 1 h (in men) and 2 h (in women) after meal intakes. This was related to pancreatic and/or intestinal and/or biliary secretions of the drug, followed by reabsorption and conversion of the R- to the S-isomer. The lower intestinal pH reported for men would lead to a higher oral bioavailability of the Test formulation and a higher reabsorption of both ketoprofen isomers in this sex. Hence, a higher rise of the S/R concentration ratio could be observed in men. No significant differences between isomers exposure were detected in both sexes after the Reference administration. Different lag times were observed after fed and fasting administration of this formulation; however, drug absorption coincided with food ingestion. Then, drug recirculation affected the S/R ratio from the beginning of drug exposure, minimizing the difference between isomers disposition.

Conclusions

R-to-S conversion rate could be mainly associated with several passages of the drug through the intestinal mucosa. The concentration–time profiles of ketoprofen in plasma after the administration of both formulations evidenced R-to-S conversion of recirculating drug following meal intakes.
Literature
1.
go back to reference Brunton LL, Chabner BA, Knollmann BC, editors. Analgesic-antipyretic and anti-inflammatory agents: pharmacotherapy of gout. In: Goodman & Gilman’s the pharmacological basis of therapeutics. 12th ed. New York: Mc Graw-Hill Professional; 2010. p. 434–6. Brunton LL, Chabner BA, Knollmann BC, editors. Analgesic-antipyretic and anti-inflammatory agents: pharmacotherapy of gout. In: Goodman & Gilman’s the pharmacological basis of therapeutics. 12th ed. New York: Mc Graw-Hill Professional; 2010. p. 434–6.
2.
go back to reference Furst DE, Ulrich RW, Prakash S. Nonsteroidal anti-inflammatory drugs, disease-modifying antirheumatic drugs, nonopioid analgesics, and drugs used in gout. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and clinical pharmacology. 12th ed. New York: Mc Graw-Hill Professional; 2012. p. 636–8. Furst DE, Ulrich RW, Prakash S. Nonsteroidal anti-inflammatory drugs, disease-modifying antirheumatic drugs, nonopioid analgesics, and drugs used in gout. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and clinical pharmacology. 12th ed. New York: Mc Graw-Hill Professional; 2012. p. 636–8.
3.
go back to reference Jamali F, Brocks DR. Clinical pharmacokinetics of ketoprofen and its enantiomers. Clin Pharmacokinet. 1990;19:197–217.CrossRefPubMed Jamali F, Brocks DR. Clinical pharmacokinetics of ketoprofen and its enantiomers. Clin Pharmacokinet. 1990;19:197–217.CrossRefPubMed
4.
go back to reference Jamali F, Russell AS, Foster RT, Lemko C. Ketoprofen pharmacokinetics in humans: evidence of enantiomeric inversion and lack of interaction. J Pharm Sci. 1990;79:460–1.CrossRefPubMed Jamali F, Russell AS, Foster RT, Lemko C. Ketoprofen pharmacokinetics in humans: evidence of enantiomeric inversion and lack of interaction. J Pharm Sci. 1990;79:460–1.CrossRefPubMed
5.
go back to reference Shi D, Jin Y, Tang Y, Hu H, Xu S, Yu L, Jiang H, Zeng S. Stereoselective binding of mexiletine and ketoprofen enantiomers with human serum albumin domains. Acta Pharmacol Sin. 2012;33:710–6.CrossRefPubMedPubMedCentral Shi D, Jin Y, Tang Y, Hu H, Xu S, Yu L, Jiang H, Zeng S. Stereoselective binding of mexiletine and ketoprofen enantiomers with human serum albumin domains. Acta Pharmacol Sin. 2012;33:710–6.CrossRefPubMedPubMedCentral
6.
go back to reference Barbanoj MJ, Antonijoan RM, Gich I. Clinical pharmacokinetics of dexketoprofen. Clin Pharmacokinet. 2001;40:245–62.CrossRefPubMed Barbanoj MJ, Antonijoan RM, Gich I. Clinical pharmacokinetics of dexketoprofen. Clin Pharmacokinet. 2001;40:245–62.CrossRefPubMed
7.
go back to reference Foster RT, Jamali F. Stereoselective pharmacokinetics of ketoprofen in the rat: influence of route of administration. Drug Metab Dispos. 1988;16:623–6.PubMed Foster RT, Jamali F. Stereoselective pharmacokinetics of ketoprofen in the rat: influence of route of administration. Drug Metab Dispos. 1988;16:623–6.PubMed
8.
go back to reference Rudy C, Liu Y, Craig D, Hall D. Stereoselective inversion pharmacokinetics of (R)—ketoprofen in healthy volunteers. J Clin Pharmacol. 1998;38:3S–10S.CrossRefPubMed Rudy C, Liu Y, Craig D, Hall D. Stereoselective inversion pharmacokinetics of (R)—ketoprofen in healthy volunteers. J Clin Pharmacol. 1998;38:3S–10S.CrossRefPubMed
9.
go back to reference Grubb NG, Rudy DW, Brater DC, Hall SD. Stereoselective pharmacokinetics of ketoprofen and ketoprofen glucuronide in end-stage renal disease: evidence for a “futile cycle” of elimination. Br J Clin Pharmacol. 1999;48:494–500.CrossRefPubMedPubMedCentral Grubb NG, Rudy DW, Brater DC, Hall SD. Stereoselective pharmacokinetics of ketoprofen and ketoprofen glucuronide in end-stage renal disease: evidence for a “futile cycle” of elimination. Br J Clin Pharmacol. 1999;48:494–500.CrossRefPubMedPubMedCentral
10.
go back to reference Mauleon D, Mis R, Ginesta J, Ortega E, Vilageliu J, Basi N, Carganico G. Pharmacokinetics of ketoprofen enantiomers in monkeys following single and multiple oral administration. Chirality. 1994;6:537–42.CrossRefPubMed Mauleon D, Mis R, Ginesta J, Ortega E, Vilageliu J, Basi N, Carganico G. Pharmacokinetics of ketoprofen enantiomers in monkeys following single and multiple oral administration. Chirality. 1994;6:537–42.CrossRefPubMed
11.
go back to reference Mustonen K, Niemi A, Raekallio M, Heinonen M, Peltoniemi O, Palviainen M, Siven M, Peltoniemi M, Vainio O. Enantiospecific ketoprofen concentrations in plasma after oral and intramuscular administration in growing pigs. Acta Vet Scand. 2012;54:55.CrossRefPubMedPubMedCentral Mustonen K, Niemi A, Raekallio M, Heinonen M, Peltoniemi O, Palviainen M, Siven M, Peltoniemi M, Vainio O. Enantiospecific ketoprofen concentrations in plasma after oral and intramuscular administration in growing pigs. Acta Vet Scand. 2012;54:55.CrossRefPubMedPubMedCentral
12.
go back to reference Fagiolino P, Vazquez M, Alvariza S, Maldonado C, Ibarra M, Olano I. Antiepileptic drugs: energy-consuming processes governing drug disposition. Front Biosci. 2014;E6:387–96.CrossRef Fagiolino P, Vazquez M, Alvariza S, Maldonado C, Ibarra M, Olano I. Antiepileptic drugs: energy-consuming processes governing drug disposition. Front Biosci. 2014;E6:387–96.CrossRef
13.
go back to reference Milne MD, Scribner BH, Crawford MA. Non-ionic diffusion and the excretion of weak acids and bases. Am J Med. 1958;24:709–29.CrossRefPubMed Milne MD, Scribner BH, Crawford MA. Non-ionic diffusion and the excretion of weak acids and bases. Am J Med. 1958;24:709–29.CrossRefPubMed
14.
go back to reference Ingraham RC, Visscher MB. Studies on the elimination of dyes in the gastric and pancreatic secretions, and inferences therefrom concerning the mechanisms of secretion of acid and base. J Gen Physiol. 1935;18:695–716.CrossRefPubMedPubMedCentral Ingraham RC, Visscher MB. Studies on the elimination of dyes in the gastric and pancreatic secretions, and inferences therefrom concerning the mechanisms of secretion of acid and base. J Gen Physiol. 1935;18:695–716.CrossRefPubMedPubMedCentral
15.
go back to reference Shohin IE, Kulinich JI, Ramenskaya GV, Abrahamsson B, Kopp S, Langguth P, Polli JE, Shah VP, Groot DW, Barends DM, Dressman JB. Biowaiver monographs for immediate-release solid oral dosage form: ketoprofen. J Pharm Sci. 2012;101:3593–603.CrossRefPubMed Shohin IE, Kulinich JI, Ramenskaya GV, Abrahamsson B, Kopp S, Langguth P, Polli JE, Shah VP, Groot DW, Barends DM, Dressman JB. Biowaiver monographs for immediate-release solid oral dosage form: ketoprofen. J Pharm Sci. 2012;101:3593–603.CrossRefPubMed
16.
go back to reference Hall JE, editor. Secretory functions of the alimentary tract. In: Guyton and Hall textbook of medical physiology. 12th ed. Philadelphia: Saunders; 2006. p. 799–802. Hall JE, editor. Secretory functions of the alimentary tract. In: Guyton and Hall textbook of medical physiology. 12th ed. Philadelphia: Saunders; 2006. p. 799–802.
17.
go back to reference He X, Lin R, He H, Sun M, Xiao D. Chiral separation of ketoprofen on a chirobiotic T column and its chiral recognition mechanisms. Chromatographia. 2012;75:1355–63.CrossRef He X, Lin R, He H, Sun M, Xiao D. Chiral separation of ketoprofen on a chirobiotic T column and its chiral recognition mechanisms. Chromatographia. 2012;75:1355–63.CrossRef
18.
go back to reference Kafková B, Bosáková Z, Tesařová E, Coufal P. Chiral separation of beta-adrenergic antagonists, profen non-steroidal anti-inflammatory drugs and chlorophenoxypropionic acid herbicides using teicoplanin as the chiral selector in capillary liquid chromatography. J Chromatogr A. 2005;1088:82–93.CrossRefPubMed Kafková B, Bosáková Z, Tesařová E, Coufal P. Chiral separation of beta-adrenergic antagonists, profen non-steroidal anti-inflammatory drugs and chlorophenoxypropionic acid herbicides using teicoplanin as the chiral selector in capillary liquid chromatography. J Chromatogr A. 2005;1088:82–93.CrossRefPubMed
19.
go back to reference Podzeck F, Newton JM, Wilding IR, Kenyon CJ. The effect of food on the gastrointestinal transit and systemic absorption of naproxen from a novel sustained release formulation. J Control Release. 1996;41:291–3.CrossRef Podzeck F, Newton JM, Wilding IR, Kenyon CJ. The effect of food on the gastrointestinal transit and systemic absorption of naproxen from a novel sustained release formulation. J Control Release. 1996;41:291–3.CrossRef
20.
go back to reference Magallanes L, Lorier M, Ibarra M, Guevara N, Vázquez M, Fagiolino P. Sex and food influence on intestinal absorption of ketoprofen gastroresistant formulation. Clin Pharmacol Drug Develop. 2015. doi:10.1002/cpdd.2008. Magallanes L, Lorier M, Ibarra M, Guevara N, Vázquez M, Fagiolino P. Sex and food influence on intestinal absorption of ketoprofen gastroresistant formulation. Clin Pharmacol Drug Develop. 2015. doi:10.​1002/​cpdd.​2008.
21.
go back to reference Geisslinger G, Menzel S, Wissel K, Brune K. Pharmacokinetics of ketoprofen enantiomers after different doses of the racemate. Br J Clin Pharmacol. 1995;40:73–5.CrossRefPubMedPubMedCentral Geisslinger G, Menzel S, Wissel K, Brune K. Pharmacokinetics of ketoprofen enantiomers after different doses of the racemate. Br J Clin Pharmacol. 1995;40:73–5.CrossRefPubMedPubMedCentral
22.
go back to reference Tuo B, Wen G, Wei J, Liu X, Wang X, Zhang Y, Wu H, Dong X, Chow JYC, Vallon V, Dong H. Estrogen regulation of duodenal bicarbonate secretion and sex-specific protection of human duodenum. Gastroenterology. 2011;141:854–63.CrossRefPubMedPubMedCentral Tuo B, Wen G, Wei J, Liu X, Wang X, Zhang Y, Wu H, Dong X, Chow JYC, Vallon V, Dong H. Estrogen regulation of duodenal bicarbonate secretion and sex-specific protection of human duodenum. Gastroenterology. 2011;141:854–63.CrossRefPubMedPubMedCentral
23.
go back to reference Vessey MP, Villard-Mackintosh LD, Painter R, Phil D. Oral contraceptives and pregnancy in relation to peptic ulcer. Contraception. 1992;46:349–57.CrossRefPubMed Vessey MP, Villard-Mackintosh LD, Painter R, Phil D. Oral contraceptives and pregnancy in relation to peptic ulcer. Contraception. 1992;46:349–57.CrossRefPubMed
Metadata
Title
Stereoselective Pharmacokinetics of Ketoprofen After Oral Administration of Modified-Release Formulations in Caucasian Healthy Subjects
Authors
Marianela Lorier
Laura Magallanes
Manuel Ibarra
Natalia Guevara
Marta Vázquez
Pietro Fagiolino
Publication date
01-12-2016
Publisher
Springer International Publishing
Published in
European Journal of Drug Metabolism and Pharmacokinetics / Issue 6/2016
Print ISSN: 0378-7966
Electronic ISSN: 2107-0180
DOI
https://doi.org/10.1007/s13318-015-0313-2

Other articles of this Issue 6/2016

European Journal of Drug Metabolism and Pharmacokinetics 6/2016 Go to the issue

Acknowledgement to Referees

Acknowledgements